Veris Health Launches Pilot Program for Veris Cancer Care Platform

Veris Health Launches Pilot Program for Veris Cancer Care Platform

By
Elena Rossi
2 min read

Veris Health and Ohio State University Launch Cancer Care Pilot Program

Pavmed's digital health subsidiary, Veris Health, has partnered with the Ohio State University Comprehensive Cancer Center to introduce a pilot program for the Veris Cancer Care platform (CCP). This collaborative digital tool encompasses remote data collection, symptom reporting, telehealth, and electronic health record (EHR) features, with the aim of enhancing comprehensive cancer care. Patients enrolled in the pilot will be equipped with a VerisBox, incorporating Bluetooth-enabled healthcare devices to transmit clinical data to their care team via a smartphone app and a cloud-based clinician portal.

James Mitchell, Veris' Chief Medical Officer, is enthusiastic about the potential of the pilot to offer personalized cancer care and reduce unplanned hospitalizations by detecting complications early. The adoption of remote patient monitoring (RPM) devices is on the rise in the healthcare industry, with the RPM market projected to reach $760 million by 2030, indicating a significant shift in patient monitoring outside traditional healthcare settings.

Key Takeaways

  • The collaboration between Pavmed's Veris Health and Ohio State University introduces a pilot program for the Veris Cancer Care platform
  • Veris Cancer Care Platform (CCP) incorporates remote data collection, telehealth, and EHR integration
  • Patients receive a VerisBox with Bluetooth-enabled healthcare devices for remote monitoring
  • The pilot aims to reduce unplanned hospitalizations by detecting complications early
  • The remote patient monitoring market is projected to reach $760 million by 2030

Analysis

Pavmed's partnership with Ohio State University for the Veris Cancer Care Platform (CCP) pilot program utilizes remote patient monitoring to improve cancer care, potentially decreasing hospitalizations. This aligns with the growing trend of the RPM market, expected to reach $760 million by 2030. The integration of RPM devices like the VerisBox could lead to personalized treatment plans and enhanced patient outcomes. In the short term, the pilot may validate the effectiveness of RPM in cancer care, influencing broader adoption. Long-term success could redefine cancer care delivery, impacting healthcare providers, patients, and stakeholders in the digital health sector.

Did You Know?

  • Veris Cancer Care Platform (CCP): Developed by Pavmed's subsidiary, Veris Health, in collaboration with Ohio State University, this digital health tool enhances comprehensive cancer care through remote data collection, symptom reporting, telehealth, and EHR features.
  • VerisBox: Equipped with Bluetooth-enabled healthcare devices, this kit is provided to patients in the pilot program, enabling remote patient monitoring by transmitting clinical data to the care team.
  • Remote Patient Monitoring (RPM): A healthcare delivery method utilizing medical devices for remote data collection and transmission to healthcare providers, aiding in early detection of complications and potentially reducing unplanned hospitalizations.

You May Also Like

This article is submitted by our user under the News Submission Rules and Guidelines. The cover photo is computer generated art for illustrative purposes only; not indicative of factual content. If you believe this article infringes upon copyright rights, please do not hesitate to report it by sending an email to us. Your vigilance and cooperation are invaluable in helping us maintain a respectful and legally compliant community.

Subscribe to our Newsletter

Get the latest in enterprise business and tech with exclusive peeks at our new offerings